COMMUNIQUÉS West-GlobeNewswire

Trinity Biotech to Announce Q2 2024 Financial Results
13/08/2024
Conference Call Scheduled for Wednesday, August 14, 2024 at 8:30 AM ET DUBLIN, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused on [...]
Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
13/08/2024
Advanced to Cohort 6 in the Phase 1 dose-escalation clinical study of BDC-3042 in patients with advanced cancers Abstract accepted for BDC-4182, a claudin 18.2-targeting Boltbody TM ISAC at the Society for Immunotherapy [...]
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024
13/08/2024
PORTLAND, Maine, Aug. 13, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and [...]
Fate Therapeutics Reports Second Quarter 2024 Financial Results and Business Updates
13/08/2024
Enrollment Ongoing with FT819 1XX CAR T-cell Product Candidate in Phase 1 Autoimmunity Study; Single-agent Cyclophosphamide Included as Alternative Conditioning Regimen First Patient Treated with FT522 CAR NK Cell [...]
Gritstone bio Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
13/08/2024
-- Preliminary randomized Phase 2 data suggest GRANITE (personalized neoantigen vaccine) could drive meaningful clinical benefit in front-line metastatic microsatellite-stable colorectal cancer (MSS-CRC); mature [...]
Dyadic Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress
13/08/2024
Alternative Proteins Entered into a development and commercialization partnership for the sale of animal-free recombinant albumin products with Proliant Health and Biologicals Entered into a joint development agreement [...]
Asensus Surgical, Inc. Reports Operating and Financial Results for the Second Quarter 2024
13/08/2024
RESEARCH TRIANGLE PARK, N.C., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical , Inc. (NYSE American: ASXC), a global leader of innovative digital solutions for the operating room, announced its operating and [...]
NeuroPace Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
13/08/2024
-- Revenue grew to $19.3 million in Q2 2024, a 17% increase over Q2 2023 -- -- Increased full-year 2024 revenue guidance to $76 million to $78 million -- -- Demonstrated continued operating discipline as evidenced by [...]
Tenax Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
13/08/2024
Raised Gross Proceeds of Approximately $100 Million in a Private Placement with Leading Institutional Healthcare Investors Continuing to Enroll Patients in Phase 3 LEVEL Study with 39 Investigative Sites Initiated In [...]
Mineralys Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
13/08/2024
– Advance-HTN trial is approximately 90% enrolled; trial is anticipated to deliver topline data in Q1 2025 – – Enrollment ahead of schedule in Phase 3 pivotal Launch-HTN trial and on track to deliver topline data as [...]
BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update
13/08/2024
MELVILLE, N.Y., Aug. 13, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a regenerative medicine innovator focused on stem cell-based therapies and [...]
Better Choice Company Inc. Announces Second Quarter 2024 Results
13/08/2024
Net Income Increased 190% to $2.7 million Year-Over-Year E PS Growth of 170% to $2.98 Year-Over-Year Adjusted EBITDA Increased 98% to less than $(0.1) million 1 Year-Over-Year Recognized $3.6 million Gain on [...]
Zevra Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights
13/08/2024
FDA advisory committee voted favorably that the data support arimoclomol as effective treatment for patients with NPC; PDUFA date of September 21, 2024 Pro forma June 30, 2024, cash, cash equivalents, investments and [...]
Singular Genomics Reports Recent Highlights and Second Quarter 2024 Financial Results
13/08/2024
SAN DIEGO, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and [...]
Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update
13/08/2024
Dosed the first patient in the Phase 1b arm of the clinical trial evaluating ELVN-001 in patients with CML that is relapsed, refractory or intolerant to available TKIs Dosed the first patient in the Phase 1a clinical [...]
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
13/08/2024
BOSTON, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare [...]
Achieve Life Sciences Reports Financial Results for Second Quarter 2024 and Provides Corporate Update
13/08/2024
Company to host conference call at 4:30 PM EDT today, Tuesday, August 13, 2024 SEATTLE and VANCOUVER, British Columbia, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage [...]
Korro Reports Second Quarter 2024 Financial Results and Provides Business Updates
13/08/2024
— Regulatory filing of first-in-human (FIH) trial of KRRO-110 in patients with alpha-1 antitrypsin deficiency (AATD) anticipated in the second half of 2024 — Preclinical data presented at the American Thoracic Society [...]
iCAD Reports Financial Results for Second Quarter Ended June 30, 2024
13/08/2024
NASHUA, N.H., Aug. 13, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast [...]

Pages